Physician profile
Donna Breen
NPI 1558381467
$792.94
in general payments reported to CMS, 2019-2025
7 companies · $225 in 2025
The $225 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.06 · 2020: $29.61 · 2021: $211 · 2022: $104 · 2023: $124 · 2024: $86.73 · 2025: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $326 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $325.88 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $109.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $227.04 | 2019-2022 | |
| Boston Scientific Corporation | $158.92 | 2021-2025 | General - Therapies |
| Abbvie INC. | $149.13 | 2023-2025 | |
| Genzyme Corporation | $142.58 | 2024-2025 | |
| Galderma Laboratories, L.P. | $62.81 | 2020-2024 | Dysport |
| Glaxosmithkline, LLC. | $40.58 | 2025 | Nucala |
| Optinose US, INC. | $11.88 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donna Breen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.